Research & Development



  黎舟瞳孔縮了一下,拽了他的手過來,探手在他嘴角抹了一下,冰涼的觸感讓繃緊的胳膊放松了點。   首節打完,和媒體們賽前預料的一樣,魔術隊實力上全方位佔優勢,老鷹隊這邊盡管主力打滿了首節,還是以21比27落後魔術隊6分。撸啊撸   黎江推他一下,不太樂意。超碰免费视频公开人人   今天的比賽有一次反擊,本來想扣籃,但最後還是上籃結束的進攻,因為……誰知道能不能扣得進啊!勉扣就是很有可能砸在籃筐上,那多丟臉!   晚上的時候果然有人送來了花膠魚翅湯,黎舟一口沒動,有些看著是關愛,卻同毒藥沒什麼兩樣。caoporn 第2章 歸途

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo